PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy.
作者： Hans-Jürgen Wester , Margret Schottelius
DOI: 10.1053/J.SEMNUCLMED.2019.02.008
关键词: Medicine 、 Prostate cancer 、 Radioguided Surgery 、 Radioligand 、 Cancer research 、 Membrane antigen 、 Antigen 、 Monoclonal antibody 、 Molecular targets
摘要: … While the low kidney uptake of PSMA-617 in comparison to PSMA I&T has often been … almost identical kidney clearance kinetics of 177 Lu-PSMA I&T and 177 Lu-PSMA-617 in men. …
sci-hub.se 参考文章(106)
Klára Hlouchová, Cyril Bařinka, Vojtěch Klusák, Pavel Šácha, Petra Mlčochová, Pavel Majer, Lubomír Rulíšek, Jan Konvalinka, Biochemical characterization of human glutamate carboxypeptidase III. Journal of Neurochemistry. ,vol. 101, pp. 682- 696 ,(2006) , 10.1111/J.1471-4159.2006.04341.X
David T. Price, Cary N. Robertson, Steven W. Baldwin, Matthew D. Orr, R. Edward Coleman, Thomas J. Polascik, Shuyan Wang, Timothy R. DeGrado, Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Research. ,vol. 61, pp. 110- 117 ,(2001)
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. ,vol. 136, ,(2015) , 10.1002/IJC.29210
Tanushree Ganguly, Shorouk Dannoon, Mark R. Hopkins, Stephanie Murphy, Hendry Cahaya, Joseph E. Blecha, Salma Jivan, Christopher R. Drake, Cyril Barinka, Ella F. Jones, Henry F. VanBrocklin, Clifford E. Berkman, A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer. Nuclear Medicine and Biology. ,vol. 42, pp. 780- 787 ,(2015) , 10.1016/J.NUCMEDBIO.2015.06.003
Toshihiko Hara, Hiroichi Kishi, Noboru Kosaka, Development of 18F-Fluoroethylcholine for Cancer Imaging with PET: Synthesis, Biochemistry, and Prostate Cancer Imaging The Journal of Nuclear Medicine. ,vol. 43, pp. 187- 199 ,(2002)
S. P. Rowe, K. L. Gage, S. F. Faraj, K. J. Macura, T. C. Cornish, N. Gonzalez-Roibon, G. Guner, E. Munari, A. W. Partin, C. P. Pavlovich, M. Han, H. B. Carter, T. J. Bivalacqua, A. Blackford, D. Holt, R. F. Dannals, G. J. Netto, M. A. Lodge, R. C. Mease, M. G. Pomper, S. Y. Cho, 18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer The Journal of Nuclear Medicine. ,vol. 56, pp. 1003- 1010 ,(2015) , 10.2967/JNUMED.115.154336
Sangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A. Foss, Alexander Falk, Youngjoo Byun, Sridhar Nimmagadda, Ronnie C. Mease, Martin G. Pomper, Effect of Chelators on the Pharmacokinetics of 99mTc-Labeled Imaging Agents for the Prostate-Specific Membrane Antigen (PSMA) Journal of Medicinal Chemistry. ,vol. 56, pp. 6108- 6121 ,(2013) , 10.1021/JM400823W
Andrew X. Zhang, Ryan P. Murelli, Cyril Barinka, Julien Michel, Alexandra Cocleaza, William L. Jorgensen, Jacek Lubkowski, David A. Spiegel, A Remote Arene-Binding Site on Prostate Specific Membrane Antigen Revealed by Antibody-Recruiting Small Molecules. Journal of the American Chemical Society. ,vol. 132, pp. 12711- 12716 ,(2010) , 10.1021/JA104591M
Ying Chen, Catherine A. Foss, Youngjoo Byun, Sridhar Nimmagadda, Mrudula Pullambhatla, James J. Fox, Mark Castanares, Shawn E. Lupold, John W. Babich, Ronnie C. Mease, Martin G. Pomper, Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer Journal of Medicinal Chemistry. ,vol. 51, pp. 7933- 7943 ,(2008) , 10.1021/JM801055H
A. Afshar-Oromieh, A. Malcher, M. Eder, M. Eisenhut, H. G. Linhart, B. A. Hadaschik, T. Holland-Letz, F. L. Giesel, C. Kratochwil, S. Haufe, U. Haberkorn, C. M. Zechmann, PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 40, pp. 486- 495 ,(2013) , 10.1007/S00259-012-2298-2